Deltex Medical Group plc
DTXMF
$0.0952
$0.09223,073.33%
| 06/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.52% | 51.49% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.52% | 51.49% | |||
| Cost of Revenue | -0.49% | 12.63% | |||
| Gross Profit | -0.51% | 82.81% | |||
| SG&A Expenses | -0.51% | 25.80% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.51% | 55.91% | |||
| Operating Income | 0.50% | -67.68% | |||
| Income Before Tax | 0.52% | 25.28% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.52% | 25.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.52% | 25.18% | |||
| EBIT | 0.50% | -67.68% | |||
| EBITDA | 0.51% | -67.21% | |||
| EPS Basic | 0.00% | 33.33% | |||
| Normalized Basic EPS | 0.00% | 0.00% | |||
| EPS Diluted | 0.00% | 33.33% | |||
| Normalized Diluted EPS | 0.00% | 0.00% | |||
| Average Basic Shares Outstanding | 0.00% | 14.03% | |||
| Average Diluted Shares Outstanding | 0.00% | 14.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
